ÈËÆÞÖгöÊÓƵ

Journal Article

1. Rood KM, Bianco A, Biggio JR, Smid MC, Simhan HN, Li J, Yong C, Carney PI, Croft DJ, Goffman D (2025). Real-world use of a vacuum-induced hemorrhage-control device in births <34 weeks gestational age. J Matern Fetal Neonatal Med, 38(1), 2451658. ()
2. Board A, Vivolo-Kantor A, Kim SY, Tran EL, Thomas SA, Terplan M, Smid MC, Sanjuan PM, Wright T, Davidson A, Wachman EM, Rood KM, Morse D, Chu E, Miele K (2024). Using ICD Codes Alone May Misclassify Overdoses Among Perinatal People. Am J Prev Med, 68(3), 563-570. ()
3. Tran EL, Dorsey AN, Miele K, Gilboa SM, Gosdin L, Terplan M, Sanjuan PM, Seligman NS, Wright T, Wachman EM, Smid M, Henninger M, Leeman L, Schneider PD, Rood K, Louis JM, Caveglia S, Davidson A, Shakib J, Shrestha H, Meaney-Delman DM, Kim SY (2024). Patterns of Medication for Opioid Use Disorder During Pregnancy, 7 Clinical Sites, MATernaL and Infant clinical NetworK (MAT-LINK), 2014-2021. J Addict Med. ()
4. Iacob E, Kausler R, Williams M, Simonsen S, Smid M, Weissinger K, Latendresse G (2024). Protocol for a randomized controlled trial to evaluate the effectiveness of a telehealth group intervention to reduce perinatal depressive symptoms. Contemp Clin Trials, 147, 107738. ()
5. Jawish R, Smid M, Gordon A, Shangraw K, Mickey BJ (2024). Prolonged transcranial magnetic stimulation in a pregnant patient with treatment-resistant depression: a case report. J Med Case Rep, 18(1), 512. ()
6. Nabi R, Bonvini M, Kennedy EH, Huang MY, Smid M, Scharfstein DO (2022). Semiparametric sensitivity analysis: unmeasured confounding in observational studies. Biometrics, 80(4). ()
7. Seliski N, Madsen T, Eley S, Colosimo J, Engar T, Gordon A, Barnett C, Humiston G, Morsillo T, Stolebarger L, Smid MC, Cochran G (2024). Implementation of a rural emergency department-initiated buprenorphine program in the mountain west: a study protocol. Addict Sci Clin Pract, 19(1), 63. ()
8. Kurtz T, Charron E, Shakib J, Smid MC (2024). Drug Testing Interpretation in the Peripartum Setting: Results of Clinician Survey. J Addict Med, 18(5), 595-598. ()
9. Maylott SE, Reese SE, Zhou AM, Kaliush PR, Terrell S, Saenz C, Brown L, Crowell SE, Lester B, Smid MC, Shakib JH, Garland EL, Conradt E (2024). Maternal psychophysiology profiles: associations with prenatal opioid use, maternal emotion dysregulation, and newborn neurobehavior. Pediatr Res. ()
10. Smid MC, Clifton RG, Rood K, Srinivas S, Simhan HN, Casey BM, Longo M, Landau R, MacPherson C, Bartholomew A, Sowles A, Reddy UM, Rouse DJ, Bailit JL, Thorp JM Jr, Chauhan SP, Saade GR, Grobman WA, Macones GA, for the Eunice Kennedy Shriver National Institute of Child ÈËÆÞÖгöÊÓƵ and Human Development NICHD Maternal-Fetal Medicine Units MFMU Network (2024). Optimizing Opioid Prescription Quantity After Cesarean Delivery: A Randomized Controlled Trial. Obstet Gynecol, 144(2), 195-205. ()
11. Cochran G, Smid MC, Krans EE, Yu Z, Carlston K, White A, Abdulla W, Baylis J, Charron E, Okifugi A, Gordon AJ, Lundahl B, Silipigni J, Seliski N, Haaland B, Tarter R (2023). Patient navigation for pregnant individuals with opioid use disorder: Results of a randomized multi-site pilot trial. Addiction, 119(3), 544-556. ()
12. Atluru S, Bruehlman AK, Vaughn P, Schauberger CW, Smid MC (2024). Naltrexone Compared With Buprenorphine or Methadone in Pregnancy: A Systematic Review. Obstet Gynecol, 143(3), 403-410. ()
13. Smid MC, Vaughn P, Nowicki CC, Goodman DA, Zaharatos J, Campbell KA (2023). Consensus pregnancy-related criteria for suicide and unintentional overdoses using a Delphi process. Arch Womens Ment ÈËÆÞÖгöÊÓƵ, 27(1), 109-125. ()
14. Herrera CA, McPherson JA, Vladutiu CJ, Smid MC (2023). Neonatal morbidity associated with maternal Group B Streptococcal colonization in individuals undergoing planned cesarean delivery. J Matern Fetal Neonatal Med, 36(1), 2183740. ()
15. Charron E, White A, Carlston K, Abdullah W, Baylis JD, Pierce S, Businelle MS, Gordon AJ, Krans EE, Smid MC, Cochran G (2023). Prospective acceptability of digital phenotyping among pregnant and parenting people with opioid use disorder: A multisite qualitative study. Front Psychiatry, 14, 1137071. ()
16. Bruno AM, Horns JJ, Allshouse AA, Metz TD, Debbink ML, Smid MC (2023). Association Between Periviable Delivery and New Onset of or Exacerbation of Existing Mental ÈËÆÞÖгöÊÓƵ Disorders. Obstet Gynecol, 141(2), 395-402. ()
17. Smid MC, Allshouse AA, McMillin GA, Nunez K, Cavin T, Worden J, Buchi K, Muniyappa B, Varner MW, Cochran G, Metz TD (2022). Umbilical Cord Collection and Drug Testing to Estimate Prenatal Substance Exposure in Utah. Obstet Gynecol, 140(2), 153-162. ()
18. Kurtz T, Smid MC (2022). Challenges in Perinatal Drug Testing. Obstet Gynecol, 140(2), 163-166. ()
19. Charron E, Baylis JD, Archer S, Garets M, Bryan MA, Foringer J, Kelley AT, Smid MC, Cochran G (2022). Attitudes, Self-Efficacy, and Practices Related to Opioid Risk Assessment and Mitigation: A Comparison of ÈËÆÞÖгöÊÓƵ Care Professionals in Rural Communities. Subst Abus. (In Press). J Subst Abuse.
20. Debbink MP, Metz TD, Nelson RE, Janes SE, Kroes A, Begaye LJ, Heuser CC, Smid MC, Silver RM, Varner MW, Einerson BD (2021). Directly Measured Costs of Severe Maternal Morbidity Events during Delivery Admission Compared with Uncomplicated Deliveries. Am J Perinatol, 39(6), 567-576. ()
21. Smid MC, Terplan M (In Press). What Obstetrician-Gynecologists Should Know About Substance Use Disorders in the Perinatal Period. Obstet Gynecol. 2022 Feb 1;139(2):317-337. doi: 10.1097/AOG.0000000000004657. PMID: 34991147. Obstet Gynecol. ()
22. White A, Lundahl B, Bryan MA, Okifuji A, Smid M, Gordon AJ, Carlston K, Silipigni J, Abdullah W, Krans EE, Kenney A, Cochran G (2021). Pregnancy and the Opioid Crisis: Heightened Effects of COVID-19. J Addict Med, 16(1), e2-e4. ()
23. Smid MC, Metz TD, McMillin GA, Mele L, Casey BM, Reddy UM, Wapner RJ, Thorp JM, Saade GR, Tita ATN, Miller ES, Rouse DJ, Sibai B, Costantine MM, Mercer BM, Caritis SN, for the Eunice Kennedy Shriver National Institute of Child ÈËÆÞÖгöÊÓƵ and Human Development NICHD Maternal-Fetal Medicine Units MFMU Network (2021). Prenatal Nicotine or Cannabis Exposure and Offspring Neurobehavioral Outcomes. Obstet Gynecol, 139(1), 21-30. ()
24. Kelley AT, Smid MC, Baylis JD, Charron E, Begaye LJ, Binns-Calvey A, Archer S, Weiner S, Pettey W, Cochran G (In Press). Treatment access for opioid use disorder in pregnancy among rural and American Indian communities. J Subst Abuse Treat. 2022 May;136:108685. doi: 10.1016/j.jsat.2021.108685. Epub 2021 Dec 13. PMID: 34953636. J Subst Abuse Treat, 136, 108685. ()
25. Debbink MP, Metz TD, Nelson RE, Janes SE, Kroes A, Begaye LJ, Heuser CC, Smid MC, Silver RM, Varner MW, Einerson BD (2021). Directly Measured Costs of Severe Maternal Morbidity Events during Delivery Admission Compared with Uncomplicated Deliveries. American Journal of Perinatology. https://doi.org/10.1055/s-0041-1740237 PMID: 34856617. Am J Perinatol, 39(6), 567-576. ()
26. Cleary EM, Smid MC, Bokat C, Costantine MM, Rood KM (2021). Indicated Opioids in Pregnancy: Guidance on Providing Comprehensive Care. American Journal of Perinatology. https://doi.org/10.1055/s-0041-1739427 PMID: 34768306. Am J Perinatol. ()
27. Kelley AT, Smid MC, Baylis JD, Charron E, Binns-Calvey AE, Archer S, Weiner SJ, Begaye LJ, Cochran G (2021). Development of an unannounced standardized patient protocol to evaluate opioid use disorder treatment in pregnancy for American Indian and rural communities. Addict Sci Clin Pract, 16(1), 40. ()
28. Dude AM, Smid MC, Branch DW, West J, Meeks H, Yu Z, Fraser A, Smith K, Reddy D (2021). Interpregnancy Body Mass Index Change and Offspring Mortality Risk following the Second Pregnancy. American Journal of Perinatology. https://doi.org/10.1055/s-0041-1727230 PMID: 33878768 . Am J Perinatol, 40(4), 387-393. ()
29. Reese SE, Riquino MR, Molloy J, Nguyen V, Smid MC, Tenort B, Gezinski LB (2020). Experiences of Nursing Professionals Working With Women Diagnosed With Opioid Use Disorder and Their Newborns: Burnout and the Need for Support. Advances in Neonatal Care, 21(1), 32–40. https://doi.org/10.1097/anc.0000000000000816 PMID: 33055519. Adv Neonatal Care, 21(1), 32-40. ()
30. Cassimatis IR, Battarbee AN, Allshouse AA, Badreldin N, Vranes CM, Oler AM, Smid MC (2020). Neonatal outcomes associated with late preterm betamethasone administration in women with pregestational diabetes. Pediatrics & Neonatology, 61(6), 645–646. https://doi.org/10.1016/j.pedneo.2020.07.002 PMID: 32763054. Pediatr Neonatol, 61(6), 645-646. ()
31. Page JM, Allshouse AA, Cassimatis I, Smid MC, Arslan E, Thorsten V, Parker C, Varner MW, Dudley DJ, Saade GR, Goldenberg RL, Stoll BJ, Hogue CJ, Bukowski R, Conway D, Pinar H, Reddy UM, Silver RM (2020). Characteristics of Stillbirths Associated With Diabetes in a Diverse U.S. Cohort. Obstet Gynecol, 136(6), 1095-1102. ()
32. Venkatesh KK, Pate V, Boggess KA, Jones HE, Funk MJ, Smid MC (2020). Trends in Opioid and Psychotropic Prescription in Pregnancy in the United States From 2001 to 2015 in a Privately Insured Population : A Cross-sectional Study. Ann Intern Med, 173(11 Suppl), S19-S28. ()
33. DAlton ME, Rood KM, Smid MC, Simhan HN, Skupski DW, Subramaniam A, Gibson KS, Rosen T, Clark SM, Dudley D, Iqbal SN, Paglia MJ, Duzyj CM, Chien EK, Gibbins KJ, Wine KD, Bentum NAA, Kominiarek MA, Tuuli MG, Goffman D (2020). Intrauterine Vacuum-Induced Hemorrhage-Control Device for Rapid Treatment of Postpartum Hemorrhage. Obstetrics & Gynecology, 136(5), 882–891. https://doi.org/10.1097/aog.0000000000004138 PMID: 32909970 . Obstet Gynecol, 136(5), 882-891. ()
34. Smid MC, Schauberger CW, Terplan M, Wright TE (2020). Early lessons from maternal mortality review committees on drug-related deaths-time for obstetrical providers to take the lead in addressing addiction. American Journal of Obstetrics & Gynecology MFM, 2(4). https://doi.org/10.1016/j.ajogmf.2020.100177 PMID: 33345905. Am J Obstet Gynecol MFM, 2(4), 100177. ()
35. Bryan MA, Smid MC, Cheng M, Fortenberry KT, Kenney A, Muniyappa B, Pendergrass D, Gordon AJ, Cochran G (2020). Addressing opioid use disorder among rural pregnant and postpartum women: a study protocol. Addict Sci Clin Pract, 15(1), 33. ()
36. Smid MC, Maeda J, Stone NM, Sylvester H, Baksh L, Debbink MP, Varner MW, Metz TD (2020). Standardized Criteria for Review of Perinatal Suicides and Accidental Drug-Related Deaths. Obstet Gynecol, 136(4), 645-653. ()
37. Metz TD, Allshouse AA, Pinar H, Varner M, Smid MC, Hogue C, Dudley DJ, Bukowski R, Saade GR, Goldenberg RL, Reddy U, Silver RM (2020). Maternal Marijuana Exposure, Feto-Placental Weight Ratio, and Placental Histology. American Journal of Perinatology. https://doi.org/10.1055/s-0040-1717092 PMID: 32971561 . Am J Perinatol. ()
38. Cochran G, Smid MC, Krans EE, Bryan MA, Gordon AJ, Lundahl B, Silipigni J, Haaland B, Tarter R (2019). A pilot multisite study of patient navigation for pregnant women with opioid use disorder. Contemp Clin Trials. 87:105888. doi: 10.1016/j.cct.2019.105888. Epub 2019 Nov 12. PMID:31731006. Contemp Clin Trials, 87, 105888. ()
39. Smid MC (2019). Marijuana use among young pregnant women: more common and more harmful than we think. BJOG: an international journal of obstetrics and gynaecology, 126(12), 1498. https://doi.org/10.1111/1471-0528.15919 PMID: 31454457. BJOG, 126(12), 1498. ()
40. Smid MC (2019). Marijuana use among young pregnant women: more common and more harmful than we think. BJOG, 126(12), 1498. ()
41. Smid MC, Stone NM, Baksh L, Debbink MP, Einerson BD, Varner MW, Gordon AJ, Clark EAS (2020). Pregnancy-Associated Death in Utah: Contribution of Drug-Induced Deaths. Obstetrics and gynecology, 133(6), 1131–1140. https://doi.org/10.1097/AOG.0000000000003279 PMID: 31135726    . Obstet Gynecol, 133(6), 1131-1140. ()
42. Dotters-Katz SK, Smid MC, Tinkham S, Chuang A (2019). Impact of Preclinical Labor and Delivery Shadowing on Student Perceptions of Obstetrics and Gynecology as a Specialty and Possible Career: A Prospective Cohort. AJP Reports. DOI: 10.1055/s-0039-1695747. AJP Rep, 9(4), e361-e365.
43. Penfield-Cyr A, Monthe-Dreze C, Smid MC, Sen S (2018). Maternal BMI, Mid-pregnancy Fatty Acid Concentrations,and Perinatal Outcomes. Clin Ther, 40(10), 1659-1667.e1. ()
44. Dotters-Katz S, Panzer A, Givens M, Smid M, Chuang A (2018). Preclinical Labor-and-Delivery Shadowing: The Impact on Medical Students' Perceptions of Obstetrics and Gynecology. AJP Rep, 8(2), e64-e67. ()
45. Smid MC, Dotters-Katz SK, Vaught AJ, Vladutiu CJ, Boggess KA, Stamilio DM (2017). Maternal super obesity and risk for intensive care unit admission in the MFMU Cesarean Registry. Acta Obstet Gynecol Scand, 96(8), 976-983. ()

Review

1. Schauberger CW, Smid MC, Terplan M, Wright TE (2024). Lessons from Maternal Mortality Reviews. How Addiction Care Providers can help improve Outcomes for Pregnant, Postpartum, and Parenting people. [Review]. Subst Use Misuse, 60(3), 446-451. ()
2. Gimbel LA, Weingarten SJ, Smid MC, Hoffman MC (2024). Maternal mental health as a major contributor to maternal mortality. [Review]. Semin Perinatol, 48(6), 151943. ()
3. McMillin GA, Morad AW, Boyd JM, Johnson-Davis KL, Metz TD, Smid MC, Krasowski MD (2023). Biological Testing and Interpretation of Laboratory Results Associated with Detecting Newborns with Substance Exposure. [Review]. Clin Chem, 70(7), 934-947. ()
4. Kurtz T, Smid MC (2023). Office-Based Management of Perinatal Substance Use and Substance Use Disorder for the General Obstetrician-Gynecologist. [Review]. Obstet Gynecol Clin North Am, 50(3), 609-627. ()
5. Park Y, Dang EP, Board A, Gilboa SM, Ondersma SJ, Smid MC, Shakib JH, Mitchell KT, England LJ, Broussard CS, Meaney-Delman D, Iskander J, Kim SY (2023). Polysubstance Use in Pregnancy: Surveillance, Interventions, and Next Steps. [Review]. J Womens ÈËÆÞÖгöÊÓƵ (Larchmt), 32(9), 899-904. ()
6. Cleary EM, Smid MC, Charles JE, Jones KM, Costantine MM, Saade G, Rood KM (2021). Buprenorphine X-waiver exemption - beyond the basics for the obstetrical provider. [Review]. Am J Obstet Gynecol MFM, 3(6), 100451. ()

Editorial

1. Smid MC, Saitz R (2021). Postpartum Treatment of Individuals With Opioid Use Disorder: Maternal Risk and Need for Evidence Do Not End When Pregnancy Ends. J Addict Med, 15(4), 267-268. ()

Letter

1. Xu KY, Pappas LM, Brown TR, Jansen MO, Tardelli VS, Fidalgo TM, Levin FR, Grucza RA, Suarez EA, Smid MC, Horns JJ, Bruno AM (2025). Attention-deficit hyperactivity disorder medication discontinuation during pregnancy and resumption postpartum. [Letter to the editor]. Am J Obstet Gynecol MFM, 7(4), 101625. ()
2. Smid MC, Allshouse AA, Metz TD, Debbink MP, Charron E, Campbell K, Cochran G (2023). Co-occurring opioid and methamphetamine use disorder and severe maternal morbidity and mortality in Utah. [Letter to the editor]. Am J Obstet Gynecol MFM, 6(1), 101221. ()
3. Metz TD, Allshouse AA, McMillin GA, Silver RM, Smid MC, Haas DM, Simhan HN, Saade GR, Grobman WA, Parry S, Chung JH, Jarlenski MP (2022). Association of Cannabis Use With Nausea and Vomiting of Pregnancy. [Letter to the editor]. Obstet Gynecol, 140(2), 266-270. ()

Other

1. Scharfstein DO, Nabi R, Kennedy EH, Huang M, Bonvini M, Smid MC (2021). Semiparametric Sensitivity Analysis: Unmeasured Confounding In Observational Studies.

News

• Opioids: Leading Cause of Pregnancy-Associated Death in New Utah Moms
• Can Exercise Cause Preterm Labor?
• ÈËÆÞÖгöÊÓƵ of Utah ÈËÆÞÖгöÊÓƵ Celebrates Opening of New Substance Use and Pregnancy Clinic